SCHEMBL21801822

SCHEMBL21801822

CC(=O)c1c(-c2c(CBr)n(COCC[Si](C)(C)C)c3ncnc(Cl)c23)noc1C1CC1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 6/20 0.36
▸ NR1H4 Q96RI1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21801346 0.86 NR1H4 (0.31) RETNR1H4
SCHEMBL29182339 0.83 RET (0.35) RETNR1H4
SCHEMBL21801350 0.81 RET (0.36) RETNR1H4
SCHEMBL21801379 0.81 RET (0.34) RETNR1H4
SCHEMBL29182312 0.77 DGAT1 (0.37) RETNR1H4
SCHEMBL30341066 0.77 DGAT1 (0.37) RETNR1H4
SCHEMBL29681783 0.76 RET (0.33) RET
SCHEMBL21907256 0.76 RET (0.33) RET
SCHEMBL21801354 0.76 RET (0.39) RET
SCHEMBL30893385 0.74 RET (0.41) RETNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3849986-A1 FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS Array Biopharma, Inc. (US) 2021-07-21 — — EP disclosed
WO-2020055672-A1 FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-03-19 — — WO disclosed
Send feedback